Trials / NCT02018692
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa
Not yet recruiting Phase 1 / Phase 2 Drug / neuroprotection
- Sponsor
- Sheba Medical Center
- Treatment
- Alga Dunaliella Bardawil powder; Placebo:Starch
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 12 Years to 18 Years
- Enrollment
- 30 participants
- Started
- 2026-03-01
- Main results expected
- 2028-12-31
- Results posted
- Not yet
- Record last updated
- 2025-10-06
What the study is testing
The aim of this study is to determine whether 9-cis-beta Caroten rich D. Brdawiil extract is effective in the treatment of retinitis pigmentosa in adolescent patients.
Where it runs
Israel (1)
- Goldschleger Eye Research Institute, Sheba Medical Center,, Tel HaShomer